Message boards index | Help | Search messages | Sign in


+ UKCAB + Public area + News, events, announcments + ECAB: Press Release re sofosbuvir & other HCV drugs

ECAB: Press Release re sofosbuvir & other HCV drugs

Print
Pages: 1

Paul Clift
Member
Posts: 467
ECAB: Press Release re sofosbuvir & other HCV drugs
Posted on: June 23 2014, 03:39 pm

Dear All

The recent ECAB meeting in Lisbon, which had a focus on hepatitis, issued a press release that was driven by concerns on pricing; these concerns were expressed unanimously by all participants:

Expanded access, compassionate use programmes & affordable pricing for Sovaldi & other new HCV drugs: urgently needed by people living with hepatitis C.

"EATG demands that drug companies commit to large early access programs in countries where Sovaldi or other new hepatitis C drugs are not available because health systems cannot afford to pay. EATG demands that drug companies unequivocally support large compassionate use (or similar) programmes for seriously ill patients who cannot wait for treatment, in countries where approval for has not yet been granted"

The full statement is in the attachment.

Paul.
Logged

Print
Pages: 1

+ UKCAB + Public area + News, events, announcments + ECAB: Press Release re sofosbuvir & other HCV drugs